Table 1.
Demographic characteristics of participants (n = 301 patients).
Table 2.
Clinical characteristics of participants (n = 301 patients).
Fig 1.
The proportion of patient responses by the extent of problems reported in each EQ-5D-5L domain among non-metastatic and metastatic HER2-positive breast cancer patients.
Table 3.
Patients’ health profile across five health dimensions of EQ 5D-5L and DASS-10.
Table 4.
Breast cancer patients’ average utility scores by their demographic and clinical characteristics.
Table 5.
Factors associated with the health-state utility of patients with HER2-positive breast cancer (Tobit regression analyses).